- Home
- BCTX vs NYC Comparison
BCTX vs NYC Comparison
Compare BCTX & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCTX | NYC |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.8M | 23.5M |
| IPO Year | 2025 | 2014 |
Fundamental Metrics
Financial Performance| Metric | BCTX | NYC |
|---|---|---|
| Price | $3.39 | $8.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $40.00 | N/A |
| AVG Volume (30 Days) | ★ 274.0K | 27.2K |
| Earning Date | 06-15-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 85.28 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $56.73 |
| Revenue Next Year | $380.95 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.61 | $7.03 |
| 52 Week High | $14.68 | $16.30 |
Technical Indicators
Market Signals| Indicator | BCTX | NYC |
|---|---|---|
| Relative Strength Index (RSI) | 41.60 | 47.78 |
| Support Level | $2.98 | $7.84 |
| Resistance Level | $4.51 | $10.29 |
| Average True Range (ATR) | 0.32 | 1.03 |
| MACD | -0.02 | -0.13 |
| Stochastic Oscillator | 28.68 | 10.67 |
Price Performance
Historical ComparisonAbout BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.